Nanoform (Finland), an innovative nanoparticle medicine enabling company, today announced it has signed a GMP 1 manufacturing program (clinical development) to enhance TargTex’s Glioblastoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback